This book provides a comprehensive overview of the physiology, pathophysiology, diagnosis, medical and surgical management, and future therapies for tricuspid valve disease. It is divided into two sections. The first section covers the basics of the tricuspid valve, including anatomy, epidemiology, and clinical diagnosis with individual chapters focused on hemodynamics, echocardiography, MRI, and CT assessment. The second section examines current treatments for tricuspid valve disease including both surgical and medical management. It discusses special clinical scenarios of tricuspid valve pathology such as tricuspid regurgitation in patients with ICD and pacemaker implants and the role of tricuspid valve disease in patients with heart failure and LVAD therapy.
Tricuspid Valve Disease: A Comprehensive Guide to Evaluation and Management is an essential resource for general cardiologists, interventional cardiologists, cardiac surgeons, and innovators in the field of structural heart disease.
Part I. Tricuspid Valve Basics.
Chapter
1. Anatomy of the Tricuspid
Valve.
Chapter
2. Epidemiology, Pathophysiology and Natural History of
Tricuspid Valve Regurgitation.
Chapter
3. Epidemiology, Pathophysiology and
Natural History of Tricuspid Valve Stenosis.
Chapter
4. Clinical Assessment
of the Patient with Tricuspid Valve Disease.
Chapter
5. Hemodynamic
Assessment of Tricuspid Valve Disease.
Chapter
6. Echocardiographic
Assessment Tricuspid Valve Disease.-Chapter
7. MRI Assessment of the
Tricuspid Valve and Right Heart.
Chapter
8. CT Assessment of the Tricuspid
Valve and the Right Heart.
Chapter
9. Putting it All Together: Phenotyping
the Patient with Tricuspid Valve Disease.- Part II. Current Management of
Tricuspid Valve Disease.-Chapter
10. Medical Management of Primary Tricuspid
Regurgitation.
Chapter
11. Medical Management of Secondary Tricuspid
Regurgitation.
Chapter
12. Surgical Management of Tricuspid Valve
Disease.-Chapter
13. TricuspidRegurgitation and Right Ventricular
Dysfunction.
Chapter
14. Evaluation and Management of Tricuspid
Regurgitation in Patients with ICD/Pacemakers.
Chapter
15. Evaluation and
Management of Tricuspid Regurgitation in Patients Being Considered for
LVAD.- Part III. Forthcoming Percutaneous Therapies for Tricuspid Valve
Regurgitation.
Chapter
16. The Landscape and Potential of Percutaneous
Therapies for Tricuspid Valve Disease.
Chapter
17. Annuloplasty Based
Strategies.
Chapter
18. Coaptation Strategies.
Chapter
19. Valve
Replacement.
Hansie Mathelier, MD
Clinical Assistant Professor of Medicine
The University of Pennsylvania
Presbyterian Medical Center
Philadelphia, PA
Scott Lilly, MD, PhD
Associate Professor of Medicine
Clinical Director, Structural Heart Disease
Richard M. Ross Heart Hospital
Ohio State University
Columbus, OH
Satya Shreenivas, MD
Interventional Cardiologist
The Christ Hospital
Cincinnati, OH
